Mark B. McClellan M.D. Ph.D. serves as Independent Director of the Company. He became the inaugural Director of the Duke-Robert J. Margolis, MD, Center for Health Policy and the Margolis Professor of Business, Medicine and Policy at Duke University in January 2016. Previously, he served from 2007 to 2015 as a Senior Fellow in Economic Studies and as Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006 and as Commissioner of the U.S. Food and Drug Administration from 2002 to 2004. He served as a member of the President’s Council of Economic Advisers and as senior director for healthcare policy at the White House from 2001 to 2002 and, during President Bill Clinton’s administration, held the position of Deputy Assistant Secretary for Economic Policy for the Department of the Treasury. Dr. McClellan received his Bachelor of Arts degree from the University of Texas, his Masters of Public Administration and Medical Doctorate from Harvard University and his Doctor of Philosophy in Economics from Massachusetts Institute of Technology.
As the Independent Director of Cigna, the total compensation of Mark McClellan at Cigna is $310,365. There are 15 executives at Cigna getting paid more, with Timothy Wentworth having the highest compensation of $23,544,300.
Mark McClellan is 56, he's been the Independent Director of Cigna since 2018. There are 17 older and 12 younger executives at Cigna. The oldest executive at Cigna Group (The) is Roman Martinez, 72, who is the Independent Director.
Mark's mailing address filed with the SEC is ONE JOHNSON & JOHNSON PLAZA, , NEW BRUNSWICK, NJ, 08933.
Over the last 21 years, insiders at Cigna have traded over $319,958,441 worth of Cigna stock and bought 28,308 units worth $3,902,366 . The most active insiders traders include James E Rogers, William J Iii De Laney und Eric C Wiseman. On average, Cigna executives and independent directors trade stock every 14 days with the average trade being worth of $5,384,589. The most recent stock trade was executed by William J Iii De Laney on 19 August 2024, trading 2,691 units of CI stock currently worth $471,167.
The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.
Cigna executives and other stock owners filed with the SEC include: